Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK

13Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Macrophages (MΦs) utilize macropinocytosis to integrate immune and metabolic signals in order to initiate an effective immune response. Diabetes is characterized by metabolic abnormalities and altered immune function. Here we examine the influence of diabetes on macropinocytosis in primary mouse macrophages and in an in vitro diabetes model. Results: The data demonstrate that peritoneal MΦs from diabetic (db/ db) mice had reduced macropinocytosis when compared to MΦs from non-diabetic (db/+) mice. Additionally, MΦs cultured in hyperglycemic conditions were less adept at macropinocytosis than those cultured in low glucose. Notably, AMP-activated protein kinase (AMPK) activity was decreased in MΦs cultured in hyperglycemic conditions. Activation of AMPK with leptin or 5-aminoimidazole-4-carboxamide-1- β-riboside (AICAR) increased macropinocytosis and inhibition of AMPK with compound C decreased macropinocytosis. Conclusion: Taken together, these findings indicate that MΦs from diabetic mice have decreased macropinocytosis. This decrease appears dependent on reduced AMPK activity. These results demonstrate a previously unrealized role for AMPK in MΦs and suggest that increasing AMPK activity in diabetic MΦs could improve innate immunity and decrease susceptibility to infection. © 2008 Guest et al; licensee BioMed Central Ltd.

References Powered by Scopus

Leptin and the regulation of body weight in mammals

4697Citations
N/AReaders
Get full text

Monocyte and macrophage heterogeneity

4159Citations
N/AReaders
Get full text

AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism

2439Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Activation and signaling by the AMP-activated protein kinase in endothelial cells

266Citations
N/AReaders
Get full text

Adenosine monophosphate-activated protein kinase (AMPK) as a new target for antidiabetic drugs: A review on metabolic, pharmacological and chemical considerations

112Citations
N/AReaders
Get full text

A kinome RNAi screen identified AMPK as promoting poxvirus entry through the control of actin dynamics

76Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Guest, C. B., Chakour, K. S., & Freund, G. G. (2008). Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunology, 9. https://doi.org/10.1186/1471-2172-9-42

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

60%

Professor / Associate Prof. 8

27%

Researcher 3

10%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 20

69%

Medicine and Dentistry 3

10%

Biochemistry, Genetics and Molecular Bi... 3

10%

Immunology and Microbiology 3

10%

Save time finding and organizing research with Mendeley

Sign up for free